tiprankstipranks
Advertisement
Advertisement

HK:9606 Stock Latest News

Duality Biotherapeutics Wins Shareholder Approval for RMB Share Issue and Sci-Tech Board Listing
Company AnnouncementsDuality Biotherapeutics Wins Shareholder Approval for RMB Share Issue and Sci-Tech Board Listing
11d ago
9606
Duality Biotherapeutics Calls EGM to Approve RMB Share Issue and Sci-Tech Board Listing Framework
PremiumCompany Announcements
Duality Biotherapeutics Calls EGM to Approve RMB Share Issue and Sci-Tech Board Listing Framework
26d ago
9606
Duality Biotherapeutics Plans RMB Share Issue and Sci-Tech Board Listing
PremiumCompany Announcements
Duality Biotherapeutics Plans RMB Share Issue and Sci-Tech Board Listing
27d ago
9606
Duality Biotherapeutics Wins China BLA Acceptance for Key HER2 Breast Cancer Drug
PremiumCompany Announcements
Duality Biotherapeutics Wins China BLA Acceptance for Key HER2 Breast Cancer Drug
1M ago
9606
Duality Biotherapeutics Sets April 29, 2026 Extraordinary General Meeting and Book Closure Dates
PremiumCompany Announcements
Duality Biotherapeutics Sets April 29, 2026 Extraordinary General Meeting and Book Closure Dates
1M ago
9606
Duality Biotherapeutics: Strong ADC Portfolio and Upcoming Catalysts Support Upside and Maintain Buy Rating
PremiumRatingsDuality Biotherapeutics: Strong ADC Portfolio and Upcoming Catalysts Support Upside and Maintain Buy Rating
1M ago
Duality Biotherapeutics Narrows Adjusted Loss as Lead ADCs Hit Key Clinical Milestones
Premium
Company Announcements
Duality Biotherapeutics Narrows Adjusted Loss as Lead ADCs Hit Key Clinical Milestones
2M ago
9606
Duality Biotherapeutics Reshapes Board and Finance Leadership to Back R&D Strategy
Premium
Company Announcements
Duality Biotherapeutics Reshapes Board and Finance Leadership to Back R&D Strategy
2M ago
9606
Duality Biotherapeutics Details Board and Committee Structure
PremiumCompany Announcements
Duality Biotherapeutics Details Board and Committee Structure
2M ago
9606
Duality Biotherapeutics Sets March Board Meeting on 2025 Results and Dividend
PremiumCompany Announcements
Duality Biotherapeutics Sets March Board Meeting on 2025 Results and Dividend
2M ago
9606
Duality Biotherapeutics Reports Encouraging Prostate Cancer Data for Lead ADC at ASCO GU 2026
PremiumCompany Announcements
Duality Biotherapeutics Reports Encouraging Prostate Cancer Data for Lead ADC at ASCO GU 2026
3M ago
9606
Duality Biotherapeutics Shareholders Approve 2025 Equity Incentive Scheme and Mandate Limits
PremiumCompany Announcements
Duality Biotherapeutics Shareholders Approve 2025 Equity Incentive Scheme and Mandate Limits
4M ago
9606
Duality Biotherapeutics Proposes 2025 Share Scheme to Boost Growth
PremiumCompany AnnouncementsDuality Biotherapeutics Proposes 2025 Share Scheme to Boost Growth
5M ago
9606
Duality Biotherapeutics Announces EGM for 2025 Share Scheme Approval
Premium
Company Announcements
Duality Biotherapeutics Announces EGM for 2025 Share Scheme Approval
5M ago
9606
Duality Biotherapeutics Announces Extraordinary General Meeting
Premium
Company Announcements
Duality Biotherapeutics Announces Extraordinary General Meeting
5M ago
9606
Duality Biotherapeutics Plans RMB Share Listing on Shanghai’s Sci-Tech Board
PremiumCompany Announcements
Duality Biotherapeutics Plans RMB Share Listing on Shanghai’s Sci-Tech Board
7M ago
9606
Duality Biotherapeutics Gains Inclusion in Key Stock Indices
PremiumCompany Announcements
Duality Biotherapeutics Gains Inclusion in Key Stock Indices
8M ago
9606
Duality Biotherapeutics Achieves Key Milestone in Cancer Drug Trial
PremiumCompany Announcements
Duality Biotherapeutics Achieves Key Milestone in Cancer Drug Trial
8M ago
9606
Duality Biotherapeutics, Inc.: Strong Growth Potential and Innovation Drive Buy Rating
PremiumRatings
Duality Biotherapeutics, Inc.: Strong Growth Potential and Innovation Drive Buy Rating
8M ago
Duality Biotherapeutics Reports Strong Pipeline Progress Amid Financial Losses
PremiumCompany AnnouncementsDuality Biotherapeutics Reports Strong Pipeline Progress Amid Financial Losses
9M ago
9606
Duality Biotherapeutics Schedules Board Meeting for Interim Results
Premium
Company Announcements
Duality Biotherapeutics Schedules Board Meeting for Interim Results
9M ago
9606
Duality Biotherapeutics’ DB-1310 Receives FDA Fast Track Designation
Premium
Company Announcements
Duality Biotherapeutics’ DB-1310 Receives FDA Fast Track Designation
10M ago
9606

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >